(1st UPDATE) Enzalutamide
Lutetium Lu-177 Vipivotide Tetraxetan
Degarelix
(2nd UPDATE) Enzalutamide
NCCN Guidelines for Patients®: Prostate Cancer: Advanced Stage
Prostate Conditions Education Council (PCEC)
Urology Care Foundation
ZERO